Error
xxx
Welcome to the European Forum for Good Clinical Practice
Activities  >  Events and Activities  >  E-Consent Webinar
Webinar
E-Consent Webinar
ICH GCP defines informed consent as: A process by which a subject voluntarily confirms his or her willingness to participate in a particular trial, after having been informed of all aspects of the trial that are relevant to the subject's decision to participate. Informed consent is documented by means of a written, signed and dated informed...
23 September 2019 -- 17:00-18:00 CETAdd to calendar
DescriptionRegistration
Description

ICH GCP defines informed consent as:

A process by which a subject voluntarily confirms his or her willingness to participate in a particular trial, after having been informed of all aspects of the trial that are relevant to the subject's decision to participate. Informed consent is documented by means of a written, signed and dated informed consent form (§1.28)

In today’s environment information is given in many forms, commonly via electronic, computerised means. Every day we accept policies, terms and conditions by the ‘click’ of a button to quickly access the information we need to support decision-making in our lives. On-screen information plays an integral part of learning, with even young children accessing learning materials from school websites to supplement descriptions and discussions with their teachers.

In clinical trials, however, paper forms persist; as trials become more complex in their designs, and therapies more directed to specific patient populations, the paper informed consent and patient information form remains the ‘trusted’ mechanism for documenting that the informed consent process has taken place.

Why is this? Regulators and clinical trial researchers agree electronic informed consent processes are not prohibited by legislation, provided the principles of the informed consent process are adhered to.

EFGCP is proud to be supported by the UK Medicines and Healthcare products Regulatory Agency (MHRA) GCP Inspectorate and UK Health Research Authority (HRA) amongst our eminent guest panel for a lively presentation, discussion and debate on the topic.


We will hear from Regulators, Industry and academics about the ongoing debate that will help raising awareness amongst stakeholders for further dialogue and potential solutions. This will be followed by a Q&A discussion where you will be able to ask questions to our panel.

Agenda:

  • 17.00: Introduction by Louise Mawer (EFGCP Audit WP Chair)
  • 17.05: Presentation “eConsent in Clinical Trials of IMP” by Jennifer Martin (MHRA) and Clive Collett (HRA)
  • 17.35: Q&A session moderated by Louise Mawer
  • Panel members: Jennifer Martin (MHRA) Clive Collett (NHS, UK HRA), Matt Jones (Digital Quality Associates) and Ingrid Klingmann (EFGCP Chairman)
  • 18.00: Close of the webinar


Webinar Fee:

  • EFGCP Members: 29€
  • Non EFGCP Members: 49€
  • EFGCP offers free seats to patients (within the limit of available seats), please contact Ingrid Heyne at ingrid.heyne@efgcp.eu if you are interested.



Ask us
If you have any question, send us an email to info@efgcp.eu
Follow us
Linkedin
Twitter
EFGCP
European Forum for Good Clinical Practice
Rue de Washington 40
B-1050 Brussels - Belgium
Tel : +32 2 732 87 83
TVA : BE 0457 666 685